Mueller HW et al. |
1-O-alkyl-linked glycerophospholipids of human neutrophils: distribution of arachidonate and other acyl residues in the ether-linked and diacyl species. |
1984 |
J. Lipid Res. |
pmid:6427378
|
O'Flaherty JT et al. |
Diacylglycerols enhance human neutrophil degranulation responses: relevancy to a multiple mediator hypothesis of cell function. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6433920
|
Mendlovic F et al. |
Possible involvement of cyclooxygenase products in the actions of platelet-activating factor and of lipoxygenase products in the vascular effects of epinephrine in perfused rat liver. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6435614
|
Fouque F and Vargaftig BB |
Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation. |
1984 |
Br. J. Pharmacol. |
pmid:6439269
|
Karlsson G and Pipkorn U |
Effect of disodium chromoglycate on changes in nasal airway resistance induced by platelet activating factor. |
1984 |
Eur. J. Clin. Pharmacol. |
pmid:6439565
|
Sänze JU et al. |
On the nature of the vasoreactivity depressing factor (VDF) in inflammation and anaphylaxis in the rat and mouse. |
1984 |
Biomed. Biochim. Acta |
pmid:6440544
|
Handley DA et al. |
Effect of platelet activating factor on endothelial permeability to plasma macromolecules. |
1984 |
Immunopharmacology |
pmid:6083990
|
Camussi G et al. |
Effect of platelet activating factor on guinea-pig papillary muscle. |
1984 |
Experientia |
pmid:6086382
|
Sills RH |
Thrombotic thrombocytopenic purpura. I. Pathophysiology and clinical manifestations. |
1984 |
Am J Pediatr Hematol Oncol |
pmid:6442830
|
Lartigue-Mattei C et al. |
Pharmacokinetic study of 3H-labelled PAF-acether II. Comparison with 3H-labelled lyso-PAF-acether after intravenous administration in the rabbit and protein binding. |
1984 |
Agents Actions |
pmid:6532184
|
Kulikov VI et al. |
[Incorporation of 1-0-alkyl-2-acetyl-sn-glycerol-3-phosphocholine into human plasma lipoproteins in vitro. Effect of the lecithin:cholesterol acyltransferase activity of plasma]. |
1984 |
Biokhimiia |
pmid:6542803
|
Smith RJ et al. |
Stimulation of the human neutrophil superoxide anion-generating system with 1-O-hexadecyl/octadecyl-2-acetyl-sn-glyceryl-3- phosphorylcholine. |
1984 |
Biochem. Pharmacol. |
pmid:6324816
|
Buxton DB et al. |
Stimulation of hepatic glycogenolysis by acetylglyceryl ether phosphorylcholine. |
1984 |
J. Biol. Chem. |
pmid:6693418
|
Sakamoto H et al. |
Stimulation of leukocyte phagocytic activity by the platelet release reaction. |
1984 |
Pathology |
pmid:6462776
|
Shukla SD and Hanahan DJ |
Acetylglyceryl ether phosphorylcholine (AGEPC; platelet-activating factor)-induced stimulation of rabbit platelets: correlation between phosphatidic acid level, 45Ca2+ uptake, and [3H]serotonin secretion. |
1984 |
Arch. Biochem. Biophys. |
pmid:6465886
|
Doebber TW et al. |
Platelet activating factor intravenous infusion in rats stimulates vascular lysosomal hydrolase secretion independent of blood neutrophils. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6517949
|
Heinrich J and Zimmermann RE |
Compound 48/80 is a potent inhibitor of human platelet aggregation antagonizing the calmodulin-dependent platelet reaction in vitro. |
1984 |
Thromb. Res. |
pmid:6523451
|
Oxholm P et al. |
Lack of evidence for human lymphokines with thrombocyte aggregating activity. An in vitro study. |
1984 |
Allergy |
pmid:6528957
|
Hwang SB et al. |
Effects of nonsteroid antiinflammatory drugs on the specific binding of platelet activating factor to membrane preparations of rabbit platelets. |
1984 |
Thromb. Res. |
pmid:6429890
|
Colditz IG and Movat HZ |
Kinetics of neutrophil accumulation in acute inflammatory lesions induced by chemotaxins and chemotaxinigens. |
1984 |
J. Immunol. |
pmid:6470487
|
Patterson R et al. |
Airway responses to sequential challenges with platelet-activating factor and leukotriene D4 in rhesus monkeys. |
1984 |
J. Lab. Clin. Med. |
pmid:6470563
|
Pinckard RN et al. |
Molecular heterogeneity of platelet-activating factor produced by stimulated human polymorphonuclear leukocytes. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6743335
|
Feuerstein G et al. |
Effect of platelet-activating factor on coronary circulation of the domestic pig. |
1984 |
Am. J. Physiol. |
pmid:6703081
|
Pipkorn U et al. |
Effect of platelet activating factor on the human nasal mucosa. |
1984 |
Allergy |
pmid:6703263
|
Lüthje J and Ogilvie A |
Diadenosine triphosphate (Ap3A) mediates human platelet aggregation by liberation of ADP. |
1984 |
Biochem. Biophys. Res. Commun. |
pmid:6704102
|
Clare KA and Scrutton MC |
The role of Ca2+ uptake in the response of human platelets to adrenaline and to 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (platelet-activating factor). |
1984 |
Eur. J. Biochem. |
pmid:6705791
|
Kumar R et al. |
A facile route to semi-synthesis of acetyl glycerylether phosphoethanolamine and its choline analogue. |
1984 |
J. Lipid Res. |
pmid:6707528
|
Archer CB et al. |
Synergistic interaction between prostaglandins and PAF-acether in experimental animals and man. |
1984 |
Prostaglandins |
pmid:6203139
|
Camussi G et al. |
Platelet-activating factor-induced loss of glomerular anionic charges. |
1984 |
Kidney Int. |
pmid:6374251
|
Schlondorff D et al. |
Effect of platelet-activating factor and serum-treated zymosan on prostaglandin E2 synthesis, arachidonic acid release, and contraction of cultured rat mesangial cells. |
1984 |
J. Clin. Invest. |
pmid:6423667
|
Vargaftig BB et al. |
[Platelet aggregation and PAF-acether. Pharmacologic interference]. |
1984 |
J Pharmacol |
pmid:6374298
|
Ito S et al. |
Hyperacute renal allograft rejection in the rabbit. The role of platelet-activating factor and of cationic proteins derived from polymorphonuclear leukocytes and from platelets. |
1984 |
Lab. Invest. |
pmid:6379289
|
Bult H et al. |
Complement derived factors and prostacyclin formation by rabbit isolated peritoneum and cultured mesothelial cells. |
1984 |
Agents Actions Suppl. |
pmid:6382974
|
Hechtman HB et al. |
Role of humoral mediators in adult respiratory distress syndrome. |
1984 |
Chest |
pmid:6383742
|
Kelton JG et al. |
The detection of a platelet-agglutinating factor in thrombotic thrombocytopenic purpura. |
1984 |
Ann. Intern. Med. |
pmid:6333196
|
Bussolino F et al. |
Release of platelet-activating factor (PAF)-like material from human lymphoid cell lines. |
1984 |
Exp. Hematol. |
pmid:6333353
|
Wodzinowska B and Krajewski T |
[Role of blood platelets and their membrane in the process of hemostasis]. |
1984 Jan-Feb |
Postepy Hig Med Dosw |
pmid:6093087
|
Vemulapalli S et al. |
Cardiovascular and renal action of platelet-activating factor in anesthetized dogs. |
1984 Jul-Aug |
Hypertension |
pmid:6378787
|
Cox CP et al. |
VIP elevates platelet cyclic AMP (cAMP) levels and inhibits in vitro platelet activation induced by platelet-activating factor (PAF). |
1984 Mar-Apr |
Peptides |
pmid:6206481
|
Lenihan DJ et al. |
Involvement of platelet activating factor in physiological stress in the lizard, Anolis carolinensis. |
1985 |
Comp. Biochem. Physiol. C, Comp. Pharmacol. Toxicol. |
pmid:2861063
|
Braquet P et al. |
Involvement of platelet activating factor in respiratory anaphylaxis, demonstrated by PAF-acether inhibitor BN 52021. |
1985 |
Lancet |
pmid:2861423
|
McIntyre TM et al. |
Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. |
1985 |
J. Clin. Invest. |
pmid:2862164
|
Archer CB et al. |
Effects of serum albumin, indomethacin and histamine H1-antagonists on Paf-acether-induced inflammatory responses in the skin of experimental animals and man. |
1985 |
Br. J. Pharmacol. |
pmid:2862936
|
Leid RW and Potter KA |
Inflammation and mediators of lung injury. |
1985 |
Vet. Clin. North Am. Food Anim. Pract. |
pmid:3907779
|
Roubin R and Benveniste J |
Formation of prostaglandins, leukotrienes and paf-acether by macrophages. |
1985 |
Comp. Immunol. Microbiol. Infect. Dis. |
pmid:3910339
|
Billah MM et al. |
Platelet-activating factor metabolism in human amnion and the responses of this tissue to extracellular platelet-activating factor. |
1985 |
Prostaglandins |
pmid:3936121
|
Sybertz EJ et al. |
Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog. |
1985 |
J. Pharmacol. Exp. Ther. |
pmid:3917504
|
Doebber TW et al. |
Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2985058
|
Pfeilschifter J et al. |
Inhibition of renin secretion by platelet activating factor (acetylglyceryl ether phosphorylcholine) in cultured rat renal juxtaglomerular cells. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2985064
|
Sturk A et al. |
Synergistic effects of platelet-activating factor and other platelet agonists in human platelet aggregation and release: the role of ADP and products of the cyclooxygenase pathway. |
1985 |
Thromb. Res. |
pmid:2934863
|
Maes L et al. |
In vivo arterial platelet-vessel wall interaction and thrombosis: induction, on-line registration and ultrastructural control. |
1985 |
Adv. Exp. Med. Biol. |
pmid:3832867
|
Tamargo J et al. |
Electrophysiological effects of platelet-activating factor (PAF-acether) in guinea-pig papillary muscles. |
1985 |
Eur. J. Pharmacol. |
pmid:3996472
|
Hanahan DJ et al. |
Platelet-activating factor: a unique lipid chemical mediator. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2936201
|
Tuffin DP et al. |
Specific binding of [3H]-1-O-octadecyl Paf-acether to washed human platelets. |
1985 |
Adv. Exp. Med. Biol. |
pmid:3834789
|
Terashita Z et al. |
Is platelet activating factor (PAF) a mediator of endotoxin shock? |
1985 |
Eur. J. Pharmacol. |
pmid:3996473
|
Inoue K et al. |
Activation of guinea pig peritoneal macrophages by platelet-activating factor in free form or incorporated into liposomes. |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:2936203
|
Parente L and Flower RJ |
Hydrocortisone and 'macrocortin' inhibit the zymosan-induced release of lyso-PAF from rat peritoneal leucocytes. |
1985 |
Life Sci. |
pmid:3838566
|
Kumar R et al. |
Occurrence of glyceryl ethers in the phosphatidylcholine fraction of surfactant from dog lungs. |
1985 |
Biochim. Biophys. Acta |
pmid:3839684
|
Tokumura A and Tsukatani H |
[Antagonists of platelet activating factor]. |
1985 |
Seikagaku |
pmid:3009656
|
MacIntyre DE et al. |
Agonist-induced inositol phospholipid metabolism and Ca++ flux in human platelet activation. |
1985 |
Adv. Exp. Med. Biol. |
pmid:3010662
|
Benveniste J |
Paf-acether (platelet-activating factor). |
1985 |
Adv. Prostaglandin Thromboxane Leukot. Res. |
pmid:3159192
|
Verstraete M et al. |
An overview of antiplatelet and antithrombotic drugs. |
1985 |
Haemostasis |
pmid:3159632
|
Brain SD and Williams TJ |
Inflammatory oedema induced by synergism between calcitonin gene-related peptide (CGRP) and mediators of increased vascular permeability. |
1985 |
Br. J. Pharmacol. |
pmid:2416378
|
Touqui L et al. |
1-O-alkyl-2-acyl-sn-glycero-3-phosphorylcholine is the precursor of platelet-activating factor in stimulated rabbit platelets. Evidence for an alkylacetyl-glycerophosphorylcholine cycle. |
1985 |
Biochim. Biophys. Acta |
pmid:3967037
|
Weber N and Benning H |
Ether glycerolipids: novel substrates for studying specificity of enzymes involved in glycerolipid biosynthesis in higher plants. |
1985 |
Eur. J. Biochem. |
pmid:3967662
|
O'Neill C |
Partial characterization of the embryo-derived platelet-activating factor in mice. |
1985 |
J. Reprod. Fertil. |
pmid:4067921
|
Mallet AI and Cunningham FM |
Structural identification of platelet activating factor in psoriatic scale. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3970690
|
Valone FH |
Inhibition of binding of the platelet-activating factor AGEPC to platelets by the AGEPC analog rac-3-(N-n-octadecylcarbamoyloxy)-2-methoxypropyl 2-thiazolioethyl phosphate (CV-3988). |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3970703
|
Camussi G and Brentjens JR |
Inhalation of horseradish peroxidase by rabbits with specific IgE antibodies results in release into the circulation of platelet-activating factor and in lung lesions. |
1985 |
Clin. Immunol. Immunopathol. |
pmid:3971603
|
Darius H et al. |
Beneficial effects of a new potent and specific thromboxane receptor antagonist (SQ-29,548) in vitro and in vivo. |
1985 |
J. Pharmacol. Exp. Ther. |
pmid:2997428
|
Chesney CM et al. |
Desensitization of human platelets by platelet activating factor. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3977920
|
Nakayama R et al. |
Generation of acetyl glyceryl ether phosphorylcholine from the rat skin and muscle tissues stimulated by moxibustion. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:3977939
|
Archer CB et al. |
Accumulation of inflammatory cells in response to intracutaneous platelet activating factor (Paf-acether) in man. |
1985 |
Br. J. Dermatol. |
pmid:3978036
|
Ardaillou N et al. |
Vasoconstrictor-evoked prostaglandin synthesis in cultured human mesangial cells. |
1985 |
Am. J. Physiol. |
pmid:3918460
|
Lee TC |
Biosynthesis of platelet activating factor. Substrate specificity of 1-alkyl-2-lyso-sn-glycero-3-phosphocholine:acetyl-CoA acetyltransferase in rat spleen microsomes. |
1985 |
J. Biol. Chem. |
pmid:4030776
|
Wissner A et al. |
Analogues of platelet activating factor (PAF). 2. Some modifications of the glycerine backbone. |
1985 |
J. Med. Chem. |
pmid:4032422
|
Pritchard PH et al. |
The degradation of platelet-activating factor in the plasma of a patient with familial high density lipoprotein deficiency (Tangier disease). |
1985 |
Blood |
pmid:4063532
|
Wissner A et al. |
Analogues of platelet activating factor. 3. Replacement of the phosphate moiety with a sulfonylbismethylene group. |
1985 |
J. Med. Chem. |
pmid:4032438
|
Wimberly HC et al. |
Functional and biochemical characterization of immunologically derived equine platelet-activating factor. |
1985 |
Vet. Pathol. |
pmid:4035942
|
Ludwig JC et al. |
Modulation of platelet-activating factor (PAF) synthesis and release from human polymorphonuclear leukocytes (PMN): role of extracellular albumin. |
1985 |
Arch. Biochem. Biophys. |
pmid:4037794
|
Surles JR et al. |
Facile synthesis of platelet-activating factor and racemic analogues containing unsaturation in the sn-1-alkyl chain. |
1985 |
J. Med. Chem. |
pmid:4038418
|
Aul C et al. |
[Thrombotic thrombocytopenic purpura]. |
1985 |
Klin. Wochenschr. |
pmid:4038757
|
Hanahan DJ et al. |
A novel approach to structure proof of glyceryl ether-containing glycerophospholipids. Base-catalyzed methanolysis of platelet-activating factor (AGEPC) at 60 degrees C. |
1985 |
J. Lipid Res. |
pmid:4067422
|
Atkins JN |
Platelet-aggregating factor in thrombotic thrombocytopenic purpura. |
1985 |
Ann. Intern. Med. |
pmid:4038861
|
Pedersen AK and FitzGerald GA |
Cyclooxygenase inhibition, platelet function, and metabolite formation during chronic sulfinpyrazone dosing. |
1985 |
Clin. Pharmacol. Ther. |
pmid:3917387
|
Oda M et al. |
Molecular species of platelet-activating factor generated by human neutrophils challenged with ionophore A23187. |
1985 |
J. Immunol. |
pmid:3917470
|
Bergelson LD et al. |
Influence of platelet activation factor and prostaglandins on cholesterol esterification in human plasma. |
1985 |
FEBS Lett. |
pmid:4043408
|
Kilpatrick JM and Virella G |
Inhibition of platelet-activating factor by rabbit C-reactive protein. |
1985 |
Clin. Immunol. Immunopathol. |
pmid:4042435
|
Monnens L et al. |
Platelet aggregating factor in the epidemic form of hemolytic-uremic syndrome in childhood. |
1985 |
Clin. Nephrol. |
pmid:4042442
|
Pirotzky E et al. |
Vascular permeability induced by Paf-acether (platelet-activating factor) in the isolated perfused rat kidney. |
1985 |
Agents Actions |
pmid:4003192
|
Page CP et al. |
Platelet activating factor (Paf-acether) may account for late-onset reactions to allergen inhalation. |
1985 |
Agents Actions |
pmid:4003195
|
Page CP et al. |
Suppression of Paf-acether responses: an anti-inflammatory effect of anti-asthma drugs. |
1985 |
Agents Actions |
pmid:4003196
|
Oda M et al. |
Production of platelet-activating factor by washed rabbit platelets. |
1985 |
J. Lipid Res. |
pmid:3934305
|
O'Flaherty JT |
Neutrophil degranulation: evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE. |
1985 |
J. Cell. Physiol. |
pmid:2981891
|
Khan SN et al. |
Desaggregation of PAF-acether-aggregated platelets by verapamil and TMB-8 with reversal of phosphorylation of 40K and 20K proteins. |
1985 |
Eur. J. Pharmacol. |
pmid:3920056
|
Bushfield M et al. |
Inhibition of platelet-activating-factor-induced human platelet activation by prostaglandin D2. Differential sensitivity of platelet transduction processes and functional responses to inhibition by cyclic AMP. |
1985 |
Biochem. J. |
pmid:3002327
|
Shen TY et al. |
Characterization of a platelet-activating factor receptor antagonist isolated from haifenteng (Piper futokadsura): specific inhibition of in vitro and in vivo platelet-activating factor-induced effects. |
1985 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:2983307
|
Pannocchia A and Hardisty RM |
Cyclic AMP inhibits platelet activation independently of its effect on cytosolic free calcium. |
1985 |
Biochem. Biophys. Res. Commun. |
pmid:2983714
|
Avdonin PV et al. |
[Mechanism of increase in Ca2+ level in platelet cytoplasm induced by aggregating factors]. |
1985 |
Biokhimiia |
pmid:3000463
|
Nishihira J et al. |
Purification and characterization of the specific binding protein for platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) from human platelets. |
1985 |
Tohoku J. Exp. Med. |
pmid:3001971
|